Frontiers in Pharmacology-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2267516, encodeId=95d8226e516c2, content=相关期刊内容分享给大家，如有不对的地方欢迎纠正，一起交流学习。 最新影响因子：4.4（2023 JCR） 中科院分区：大类医学2区，小类药学2区 收录数据库：SCI-E、PubMed、Scopus、DOAJ等 OA模式：是，需支付版面费 投稿中一般1–4周就可以分配编辑，但是25存在延迟的情况，我看很多人稿件卡在“Editorial Assignment”超1个月 2-4周送审后需邀请2位以上审稿人。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms6000002977722155, createdTime=Sat May 31 22:26:33 CST 2025, time=2025-05-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2257407, encodeId=120c225e40762, content=想撤稿，应该如何操作呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6e762538727, createdName=小白白心态要稳, createdTime=Sun Mar 23 18:17:51 CST 2025, time=2025-03-23, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2256513, encodeId=928a22565139c, content=偏重的研究方向：中药 经验分享：投稿一个月了还在ea，一直没有分配编辑，焦虑 从评论区了解到该期刊的平均审稿周期是14周，个人觉得还是比较长的。 有跟我一样的朋友吗，大家一起来交流一下。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722150, createdTime=Mon Mar 17 23:15:17 CST 2025, time=2025-03-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1232891, encodeId=1d7912328916e, content=想问一下大家稿件停留在了Editorial Assignment阶段，已经三周了，编辑处显示了我选择编辑的名字，但是一直没有进展，我如果要给编辑发邮件的话，是通过Frontier的投稿官网页面给他发，还是找到编辑的邮箱私下询问呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230107/08d7227584d8419e9fc6eb0769470af8/651a32af4be94530b72739b0aea8ba0c.jpg, createdBy=ceb35641108, createdName=ms7000001549986178, createdTime=Sun Jul 17 00:40:05 CST 2022, time=2022-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2254108, encodeId=bda02254108c7, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;天然化合物;耐药 经验分享：请问投稿后遇到让重新提交的，是什么情况呢？是差什么材料，还是格式有问题吗？ Editorial Office Frontiers in Pharmacology Editorial Office requested resubmission of your manuscript. Please take action by 16 Mar 2025 on this request to either: resubmit the manuscript, or contact the editorial office., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce935708129, createdName=ms6000001686001327, createdTime=Sat Mar 01 16:25:55 CST 2025, time=2025-03-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2224267, encodeId=2f23222426e0d, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：投的综述，选择了zhulin教授担任责任编辑，特别友好。我的综述写的特别认真。3个reviewer，一个说投稿方向部队拒稿，2个接收。提的建议有水平。非常有好的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d251311964, createdName=292082, createdTime=Thu Sep 05 16:04:14 CST 2024, time=2024-09-05, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2240114, encodeId=5213224011407, content=偏重的研究方向：中药 经验分享：投稿一个月了还在ea，一直没有分配编辑，周期真的有多长了 咨询了解一下，给到的结果也是说平均审稿周期事14周，确实是比较长的。 给的建议都是让再等等，到时再发邮件委婉的问一下。 有跟我一样的朋友可以蹲一下，互相交流交流, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822132, createdTime=Sat Nov 30 22:07:30 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2247723, encodeId=d689224e72311, content=期刊主要涵盖基础和临床药理学、药物化学、药毒理学等领域。 审稿周期在2至3个月内，期刊是OA期刊，版面费按文章类型收取，A类文章（原始研究、系统评价等）版面费较高，B类（迷你评论、观点等）、C类（数据报告、综合评论等）文章版面费依次降低。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722138, createdTime=Sun Jan 12 19:07:52 CST 2025, time=2025-01-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2172843, encodeId=b0c721e284362, content=各位大神们，请问提交WB原始数据是文章中出现的就行还是要提交三次重复的WB原始数据啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb4f8508995, createdName=ms5000001006994240, createdTime=Mon Dec 04 12:19:29 CST 2023, time=2023-12-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2207562, encodeId=ea40220e5622f, content=请问这个期刊上传原始数据是怎么操作的？是全部原始数据都要上传吗？是什么阶段需要上传呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=493d8448405, createdName=ms4000000094701757, createdTime=Thu May 30 23:35:00 CST 2024, time=2024-05-30, status=1, ipAttribution=广东省)]

2025-05-31 ms6000002977722155 来自上海

相关期刊内容分享给大家，如有不对的地方欢迎纠正，一起交流学习。
最新影响因子：4.4（2023 JCR）
中科院分区：大类医学2区，小类药学2区
收录数据库：SCI-E、PubMed、Scopus、DOAJ等
OA模式：是，需支付版面费
投稿中一般1–4周就可以分配编辑，但是25存在延迟的情况，我看很多人稿件卡在“Editorial Assignment”超1个月
2-4周送审后需邀请2位以上审稿人。

5 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2267516, encodeId=95d8226e516c2, content=相关期刊内容分享给大家，如有不对的地方欢迎纠正，一起交流学习。 最新影响因子：4.4（2023 JCR） 中科院分区：大类医学2区，小类药学2区 收录数据库：SCI-E、PubMed、Scopus、DOAJ等 OA模式：是，需支付版面费 投稿中一般1–4周就可以分配编辑，但是25存在延迟的情况，我看很多人稿件卡在“Editorial Assignment”超1个月 2-4周送审后需邀请2位以上审稿人。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms6000002977722155, createdTime=Sat May 31 22:26:33 CST 2025, time=2025-05-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2257407, encodeId=120c225e40762, content=想撤稿，应该如何操作呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6e762538727, createdName=小白白心态要稳, createdTime=Sun Mar 23 18:17:51 CST 2025, time=2025-03-23, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2256513, encodeId=928a22565139c, content=偏重的研究方向：中药 经验分享：投稿一个月了还在ea，一直没有分配编辑，焦虑 从评论区了解到该期刊的平均审稿周期是14周，个人觉得还是比较长的。 有跟我一样的朋友吗，大家一起来交流一下。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722150, createdTime=Mon Mar 17 23:15:17 CST 2025, time=2025-03-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1232891, encodeId=1d7912328916e, content=想问一下大家稿件停留在了Editorial Assignment阶段，已经三周了，编辑处显示了我选择编辑的名字，但是一直没有进展，我如果要给编辑发邮件的话，是通过Frontier的投稿官网页面给他发，还是找到编辑的邮箱私下询问呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230107/08d7227584d8419e9fc6eb0769470af8/651a32af4be94530b72739b0aea8ba0c.jpg, createdBy=ceb35641108, createdName=ms7000001549986178, createdTime=Sun Jul 17 00:40:05 CST 2022, time=2022-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2254108, encodeId=bda02254108c7, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;天然化合物;耐药 经验分享：请问投稿后遇到让重新提交的，是什么情况呢？是差什么材料，还是格式有问题吗？ Editorial Office Frontiers in Pharmacology Editorial Office requested resubmission of your manuscript. Please take action by 16 Mar 2025 on this request to either: resubmit the manuscript, or contact the editorial office., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce935708129, createdName=ms6000001686001327, createdTime=Sat Mar 01 16:25:55 CST 2025, time=2025-03-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2224267, encodeId=2f23222426e0d, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：投的综述，选择了zhulin教授担任责任编辑，特别友好。我的综述写的特别认真。3个reviewer，一个说投稿方向部队拒稿，2个接收。提的建议有水平。非常有好的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d251311964, createdName=292082, createdTime=Thu Sep 05 16:04:14 CST 2024, time=2024-09-05, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2240114, encodeId=5213224011407, content=偏重的研究方向：中药 经验分享：投稿一个月了还在ea，一直没有分配编辑，周期真的有多长了 咨询了解一下，给到的结果也是说平均审稿周期事14周，确实是比较长的。 给的建议都是让再等等，到时再发邮件委婉的问一下。 有跟我一样的朋友可以蹲一下，互相交流交流, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822132, createdTime=Sat Nov 30 22:07:30 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2247723, encodeId=d689224e72311, content=期刊主要涵盖基础和临床药理学、药物化学、药毒理学等领域。 审稿周期在2至3个月内，期刊是OA期刊，版面费按文章类型收取，A类文章（原始研究、系统评价等）版面费较高，B类（迷你评论、观点等）、C类（数据报告、综合评论等）文章版面费依次降低。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722138, createdTime=Sun Jan 12 19:07:52 CST 2025, time=2025-01-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2172843, encodeId=b0c721e284362, content=各位大神们，请问提交WB原始数据是文章中出现的就行还是要提交三次重复的WB原始数据啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb4f8508995, createdName=ms5000001006994240, createdTime=Mon Dec 04 12:19:29 CST 2023, time=2023-12-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2207562, encodeId=ea40220e5622f, content=请问这个期刊上传原始数据是怎么操作的？是全部原始数据都要上传吗？是什么阶段需要上传呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=493d8448405, createdName=ms4000000094701757, createdTime=Thu May 30 23:35:00 CST 2024, time=2024-05-30, status=1, ipAttribution=广东省)]

2025-03-23 小白白心态要稳来自辽宁省

想撤稿，应该如何操作呀

21 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2267516, encodeId=95d8226e516c2, content=相关期刊内容分享给大家，如有不对的地方欢迎纠正，一起交流学习。 最新影响因子：4.4（2023 JCR） 中科院分区：大类医学2区，小类药学2区 收录数据库：SCI-E、PubMed、Scopus、DOAJ等 OA模式：是，需支付版面费 投稿中一般1–4周就可以分配编辑，但是25存在延迟的情况，我看很多人稿件卡在“Editorial Assignment”超1个月 2-4周送审后需邀请2位以上审稿人。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms6000002977722155, createdTime=Sat May 31 22:26:33 CST 2025, time=2025-05-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2257407, encodeId=120c225e40762, content=想撤稿，应该如何操作呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6e762538727, createdName=小白白心态要稳, createdTime=Sun Mar 23 18:17:51 CST 2025, time=2025-03-23, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2256513, encodeId=928a22565139c, content=偏重的研究方向：中药 经验分享：投稿一个月了还在ea，一直没有分配编辑，焦虑 从评论区了解到该期刊的平均审稿周期是14周，个人觉得还是比较长的。 有跟我一样的朋友吗，大家一起来交流一下。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722150, createdTime=Mon Mar 17 23:15:17 CST 2025, time=2025-03-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1232891, encodeId=1d7912328916e, content=想问一下大家稿件停留在了Editorial Assignment阶段，已经三周了，编辑处显示了我选择编辑的名字，但是一直没有进展，我如果要给编辑发邮件的话，是通过Frontier的投稿官网页面给他发，还是找到编辑的邮箱私下询问呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230107/08d7227584d8419e9fc6eb0769470af8/651a32af4be94530b72739b0aea8ba0c.jpg, createdBy=ceb35641108, createdName=ms7000001549986178, createdTime=Sun Jul 17 00:40:05 CST 2022, time=2022-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2254108, encodeId=bda02254108c7, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;天然化合物;耐药 经验分享：请问投稿后遇到让重新提交的，是什么情况呢？是差什么材料，还是格式有问题吗？ Editorial Office Frontiers in Pharmacology Editorial Office requested resubmission of your manuscript. Please take action by 16 Mar 2025 on this request to either: resubmit the manuscript, or contact the editorial office., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce935708129, createdName=ms6000001686001327, createdTime=Sat Mar 01 16:25:55 CST 2025, time=2025-03-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2224267, encodeId=2f23222426e0d, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：投的综述，选择了zhulin教授担任责任编辑，特别友好。我的综述写的特别认真。3个reviewer，一个说投稿方向部队拒稿，2个接收。提的建议有水平。非常有好的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d251311964, createdName=292082, createdTime=Thu Sep 05 16:04:14 CST 2024, time=2024-09-05, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2240114, encodeId=5213224011407, content=偏重的研究方向：中药 经验分享：投稿一个月了还在ea，一直没有分配编辑，周期真的有多长了 咨询了解一下，给到的结果也是说平均审稿周期事14周，确实是比较长的。 给的建议都是让再等等，到时再发邮件委婉的问一下。 有跟我一样的朋友可以蹲一下，互相交流交流, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822132, createdTime=Sat Nov 30 22:07:30 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2247723, encodeId=d689224e72311, content=期刊主要涵盖基础和临床药理学、药物化学、药毒理学等领域。 审稿周期在2至3个月内，期刊是OA期刊，版面费按文章类型收取，A类文章（原始研究、系统评价等）版面费较高，B类（迷你评论、观点等）、C类（数据报告、综合评论等）文章版面费依次降低。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722138, createdTime=Sun Jan 12 19:07:52 CST 2025, time=2025-01-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2172843, encodeId=b0c721e284362, content=各位大神们，请问提交WB原始数据是文章中出现的就行还是要提交三次重复的WB原始数据啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb4f8508995, createdName=ms5000001006994240, createdTime=Mon Dec 04 12:19:29 CST 2023, time=2023-12-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2207562, encodeId=ea40220e5622f, content=请问这个期刊上传原始数据是怎么操作的？是全部原始数据都要上传吗？是什么阶段需要上传呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=493d8448405, createdName=ms4000000094701757, createdTime=Thu May 30 23:35:00 CST 2024, time=2024-05-30, status=1, ipAttribution=广东省)]

2025-03-17 ms5000002977722150 来自上海

偏重的研究方向：中药
经验分享：投稿一个月了还在ea，一直没有分配编辑，焦虑
从评论区了解到该期刊的平均审稿周期是14周，个人觉得还是比较长的。
有跟我一样的朋友吗，大家一起来交流一下。

20 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2267516, encodeId=95d8226e516c2, content=相关期刊内容分享给大家，如有不对的地方欢迎纠正，一起交流学习。 最新影响因子：4.4（2023 JCR） 中科院分区：大类医学2区，小类药学2区 收录数据库：SCI-E、PubMed、Scopus、DOAJ等 OA模式：是，需支付版面费 投稿中一般1–4周就可以分配编辑，但是25存在延迟的情况，我看很多人稿件卡在“Editorial Assignment”超1个月 2-4周送审后需邀请2位以上审稿人。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms6000002977722155, createdTime=Sat May 31 22:26:33 CST 2025, time=2025-05-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2257407, encodeId=120c225e40762, content=想撤稿，应该如何操作呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6e762538727, createdName=小白白心态要稳, createdTime=Sun Mar 23 18:17:51 CST 2025, time=2025-03-23, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2256513, encodeId=928a22565139c, content=偏重的研究方向：中药 经验分享：投稿一个月了还在ea，一直没有分配编辑，焦虑 从评论区了解到该期刊的平均审稿周期是14周，个人觉得还是比较长的。 有跟我一样的朋友吗，大家一起来交流一下。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722150, createdTime=Mon Mar 17 23:15:17 CST 2025, time=2025-03-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1232891, encodeId=1d7912328916e, content=想问一下大家稿件停留在了Editorial Assignment阶段，已经三周了，编辑处显示了我选择编辑的名字，但是一直没有进展，我如果要给编辑发邮件的话，是通过Frontier的投稿官网页面给他发，还是找到编辑的邮箱私下询问呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230107/08d7227584d8419e9fc6eb0769470af8/651a32af4be94530b72739b0aea8ba0c.jpg, createdBy=ceb35641108, createdName=ms7000001549986178, createdTime=Sun Jul 17 00:40:05 CST 2022, time=2022-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2254108, encodeId=bda02254108c7, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;天然化合物;耐药 经验分享：请问投稿后遇到让重新提交的，是什么情况呢？是差什么材料，还是格式有问题吗？ Editorial Office Frontiers in Pharmacology Editorial Office requested resubmission of your manuscript. Please take action by 16 Mar 2025 on this request to either: resubmit the manuscript, or contact the editorial office., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce935708129, createdName=ms6000001686001327, createdTime=Sat Mar 01 16:25:55 CST 2025, time=2025-03-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2224267, encodeId=2f23222426e0d, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：投的综述，选择了zhulin教授担任责任编辑，特别友好。我的综述写的特别认真。3个reviewer，一个说投稿方向部队拒稿，2个接收。提的建议有水平。非常有好的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d251311964, createdName=292082, createdTime=Thu Sep 05 16:04:14 CST 2024, time=2024-09-05, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2240114, encodeId=5213224011407, content=偏重的研究方向：中药 经验分享：投稿一个月了还在ea，一直没有分配编辑，周期真的有多长了 咨询了解一下，给到的结果也是说平均审稿周期事14周，确实是比较长的。 给的建议都是让再等等，到时再发邮件委婉的问一下。 有跟我一样的朋友可以蹲一下，互相交流交流, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822132, createdTime=Sat Nov 30 22:07:30 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2247723, encodeId=d689224e72311, content=期刊主要涵盖基础和临床药理学、药物化学、药毒理学等领域。 审稿周期在2至3个月内，期刊是OA期刊，版面费按文章类型收取，A类文章（原始研究、系统评价等）版面费较高，B类（迷你评论、观点等）、C类（数据报告、综合评论等）文章版面费依次降低。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722138, createdTime=Sun Jan 12 19:07:52 CST 2025, time=2025-01-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2172843, encodeId=b0c721e284362, content=各位大神们，请问提交WB原始数据是文章中出现的就行还是要提交三次重复的WB原始数据啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb4f8508995, createdName=ms5000001006994240, createdTime=Mon Dec 04 12:19:29 CST 2023, time=2023-12-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2207562, encodeId=ea40220e5622f, content=请问这个期刊上传原始数据是怎么操作的？是全部原始数据都要上传吗？是什么阶段需要上传呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=493d8448405, createdName=ms4000000094701757, createdTime=Thu May 30 23:35:00 CST 2024, time=2024-05-30, status=1, ipAttribution=广东省)]

2022-07-17 ms7000001549986178

想问一下大家稿件停留在了Editorial Assignment阶段，已经三周了，编辑处显示了我选择编辑的名字，但是一直没有进展，我如果要给编辑发邮件的话，是通过Frontier的投稿官网页面给他发，还是找到编辑的邮箱私下询问呢？

92 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2267516, encodeId=95d8226e516c2, content=相关期刊内容分享给大家，如有不对的地方欢迎纠正，一起交流学习。 最新影响因子：4.4（2023 JCR） 中科院分区：大类医学2区，小类药学2区 收录数据库：SCI-E、PubMed、Scopus、DOAJ等 OA模式：是，需支付版面费 投稿中一般1–4周就可以分配编辑，但是25存在延迟的情况，我看很多人稿件卡在“Editorial Assignment”超1个月 2-4周送审后需邀请2位以上审稿人。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms6000002977722155, createdTime=Sat May 31 22:26:33 CST 2025, time=2025-05-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2257407, encodeId=120c225e40762, content=想撤稿，应该如何操作呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6e762538727, createdName=小白白心态要稳, createdTime=Sun Mar 23 18:17:51 CST 2025, time=2025-03-23, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2256513, encodeId=928a22565139c, content=偏重的研究方向：中药 经验分享：投稿一个月了还在ea，一直没有分配编辑，焦虑 从评论区了解到该期刊的平均审稿周期是14周，个人觉得还是比较长的。 有跟我一样的朋友吗，大家一起来交流一下。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722150, createdTime=Mon Mar 17 23:15:17 CST 2025, time=2025-03-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1232891, encodeId=1d7912328916e, content=想问一下大家稿件停留在了Editorial Assignment阶段，已经三周了，编辑处显示了我选择编辑的名字，但是一直没有进展，我如果要给编辑发邮件的话，是通过Frontier的投稿官网页面给他发，还是找到编辑的邮箱私下询问呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230107/08d7227584d8419e9fc6eb0769470af8/651a32af4be94530b72739b0aea8ba0c.jpg, createdBy=ceb35641108, createdName=ms7000001549986178, createdTime=Sun Jul 17 00:40:05 CST 2022, time=2022-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2254108, encodeId=bda02254108c7, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;天然化合物;耐药 经验分享：请问投稿后遇到让重新提交的，是什么情况呢？是差什么材料，还是格式有问题吗？ Editorial Office Frontiers in Pharmacology Editorial Office requested resubmission of your manuscript. Please take action by 16 Mar 2025 on this request to either: resubmit the manuscript, or contact the editorial office., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce935708129, createdName=ms6000001686001327, createdTime=Sat Mar 01 16:25:55 CST 2025, time=2025-03-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2224267, encodeId=2f23222426e0d, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：投的综述，选择了zhulin教授担任责任编辑，特别友好。我的综述写的特别认真。3个reviewer，一个说投稿方向部队拒稿，2个接收。提的建议有水平。非常有好的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d251311964, createdName=292082, createdTime=Thu Sep 05 16:04:14 CST 2024, time=2024-09-05, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2240114, encodeId=5213224011407, content=偏重的研究方向：中药 经验分享：投稿一个月了还在ea，一直没有分配编辑，周期真的有多长了 咨询了解一下，给到的结果也是说平均审稿周期事14周，确实是比较长的。 给的建议都是让再等等，到时再发邮件委婉的问一下。 有跟我一样的朋友可以蹲一下，互相交流交流, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822132, createdTime=Sat Nov 30 22:07:30 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2247723, encodeId=d689224e72311, content=期刊主要涵盖基础和临床药理学、药物化学、药毒理学等领域。 审稿周期在2至3个月内，期刊是OA期刊，版面费按文章类型收取，A类文章（原始研究、系统评价等）版面费较高，B类（迷你评论、观点等）、C类（数据报告、综合评论等）文章版面费依次降低。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722138, createdTime=Sun Jan 12 19:07:52 CST 2025, time=2025-01-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2172843, encodeId=b0c721e284362, content=各位大神们，请问提交WB原始数据是文章中出现的就行还是要提交三次重复的WB原始数据啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb4f8508995, createdName=ms5000001006994240, createdTime=Mon Dec 04 12:19:29 CST 2023, time=2023-12-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2207562, encodeId=ea40220e5622f, content=请问这个期刊上传原始数据是怎么操作的？是全部原始数据都要上传吗？是什么阶段需要上传呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=493d8448405, createdName=ms4000000094701757, createdTime=Thu May 30 23:35:00 CST 2024, time=2024-05-30, status=1, ipAttribution=广东省)]

2025-03-01 ms6000001686001327 来自上海

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤;天然化合物;耐药
经验分享：请问投稿后遇到让重新提交的，是什么情况呢？是差什么材料，还是格式有问题吗？
Editorial Office Frontiers in Pharmacology Editorial Office requested resubmission of your manuscript.

Please take action by 16 Mar 2025 on this request to either:

resubmit the manuscript, or
contact the editorial office.

28 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2267516, encodeId=95d8226e516c2, content=相关期刊内容分享给大家，如有不对的地方欢迎纠正，一起交流学习。 最新影响因子：4.4（2023 JCR） 中科院分区：大类医学2区，小类药学2区 收录数据库：SCI-E、PubMed、Scopus、DOAJ等 OA模式：是，需支付版面费 投稿中一般1–4周就可以分配编辑，但是25存在延迟的情况，我看很多人稿件卡在“Editorial Assignment”超1个月 2-4周送审后需邀请2位以上审稿人。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms6000002977722155, createdTime=Sat May 31 22:26:33 CST 2025, time=2025-05-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2257407, encodeId=120c225e40762, content=想撤稿，应该如何操作呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6e762538727, createdName=小白白心态要稳, createdTime=Sun Mar 23 18:17:51 CST 2025, time=2025-03-23, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2256513, encodeId=928a22565139c, content=偏重的研究方向：中药 经验分享：投稿一个月了还在ea，一直没有分配编辑，焦虑 从评论区了解到该期刊的平均审稿周期是14周，个人觉得还是比较长的。 有跟我一样的朋友吗，大家一起来交流一下。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722150, createdTime=Mon Mar 17 23:15:17 CST 2025, time=2025-03-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1232891, encodeId=1d7912328916e, content=想问一下大家稿件停留在了Editorial Assignment阶段，已经三周了，编辑处显示了我选择编辑的名字，但是一直没有进展，我如果要给编辑发邮件的话，是通过Frontier的投稿官网页面给他发，还是找到编辑的邮箱私下询问呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230107/08d7227584d8419e9fc6eb0769470af8/651a32af4be94530b72739b0aea8ba0c.jpg, createdBy=ceb35641108, createdName=ms7000001549986178, createdTime=Sun Jul 17 00:40:05 CST 2022, time=2022-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2254108, encodeId=bda02254108c7, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;天然化合物;耐药 经验分享：请问投稿后遇到让重新提交的，是什么情况呢？是差什么材料，还是格式有问题吗？ Editorial Office Frontiers in Pharmacology Editorial Office requested resubmission of your manuscript. Please take action by 16 Mar 2025 on this request to either: resubmit the manuscript, or contact the editorial office., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce935708129, createdName=ms6000001686001327, createdTime=Sat Mar 01 16:25:55 CST 2025, time=2025-03-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2224267, encodeId=2f23222426e0d, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：投的综述，选择了zhulin教授担任责任编辑，特别友好。我的综述写的特别认真。3个reviewer，一个说投稿方向部队拒稿，2个接收。提的建议有水平。非常有好的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d251311964, createdName=292082, createdTime=Thu Sep 05 16:04:14 CST 2024, time=2024-09-05, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2240114, encodeId=5213224011407, content=偏重的研究方向：中药 经验分享：投稿一个月了还在ea，一直没有分配编辑，周期真的有多长了 咨询了解一下，给到的结果也是说平均审稿周期事14周，确实是比较长的。 给的建议都是让再等等，到时再发邮件委婉的问一下。 有跟我一样的朋友可以蹲一下，互相交流交流, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822132, createdTime=Sat Nov 30 22:07:30 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2247723, encodeId=d689224e72311, content=期刊主要涵盖基础和临床药理学、药物化学、药毒理学等领域。 审稿周期在2至3个月内，期刊是OA期刊，版面费按文章类型收取，A类文章（原始研究、系统评价等）版面费较高，B类（迷你评论、观点等）、C类（数据报告、综合评论等）文章版面费依次降低。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722138, createdTime=Sun Jan 12 19:07:52 CST 2025, time=2025-01-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2172843, encodeId=b0c721e284362, content=各位大神们，请问提交WB原始数据是文章中出现的就行还是要提交三次重复的WB原始数据啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb4f8508995, createdName=ms5000001006994240, createdTime=Mon Dec 04 12:19:29 CST 2023, time=2023-12-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2207562, encodeId=ea40220e5622f, content=请问这个期刊上传原始数据是怎么操作的？是全部原始数据都要上传吗？是什么阶段需要上传呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=493d8448405, createdName=ms4000000094701757, createdTime=Thu May 30 23:35:00 CST 2024, time=2024-05-30, status=1, ipAttribution=广东省)]

2024-09-05 292082 来自甘肃省

审稿速度:3.0 | 投稿命中率:75.0
经验分享：投的综述，选择了zhulin教授担任责任编辑，特别友好。我的综述写的特别认真。3个reviewer，一个说投稿方向部队拒稿，2个接收。提的建议有水平。非常有好的杂志。

105 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2267516, encodeId=95d8226e516c2, content=相关期刊内容分享给大家，如有不对的地方欢迎纠正，一起交流学习。 最新影响因子：4.4（2023 JCR） 中科院分区：大类医学2区，小类药学2区 收录数据库：SCI-E、PubMed、Scopus、DOAJ等 OA模式：是，需支付版面费 投稿中一般1–4周就可以分配编辑，但是25存在延迟的情况，我看很多人稿件卡在“Editorial Assignment”超1个月 2-4周送审后需邀请2位以上审稿人。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms6000002977722155, createdTime=Sat May 31 22:26:33 CST 2025, time=2025-05-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2257407, encodeId=120c225e40762, content=想撤稿，应该如何操作呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6e762538727, createdName=小白白心态要稳, createdTime=Sun Mar 23 18:17:51 CST 2025, time=2025-03-23, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2256513, encodeId=928a22565139c, content=偏重的研究方向：中药 经验分享：投稿一个月了还在ea，一直没有分配编辑，焦虑 从评论区了解到该期刊的平均审稿周期是14周，个人觉得还是比较长的。 有跟我一样的朋友吗，大家一起来交流一下。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722150, createdTime=Mon Mar 17 23:15:17 CST 2025, time=2025-03-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1232891, encodeId=1d7912328916e, content=想问一下大家稿件停留在了Editorial Assignment阶段，已经三周了，编辑处显示了我选择编辑的名字，但是一直没有进展，我如果要给编辑发邮件的话，是通过Frontier的投稿官网页面给他发，还是找到编辑的邮箱私下询问呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230107/08d7227584d8419e9fc6eb0769470af8/651a32af4be94530b72739b0aea8ba0c.jpg, createdBy=ceb35641108, createdName=ms7000001549986178, createdTime=Sun Jul 17 00:40:05 CST 2022, time=2022-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2254108, encodeId=bda02254108c7, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;天然化合物;耐药 经验分享：请问投稿后遇到让重新提交的，是什么情况呢？是差什么材料，还是格式有问题吗？ Editorial Office Frontiers in Pharmacology Editorial Office requested resubmission of your manuscript. Please take action by 16 Mar 2025 on this request to either: resubmit the manuscript, or contact the editorial office., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce935708129, createdName=ms6000001686001327, createdTime=Sat Mar 01 16:25:55 CST 2025, time=2025-03-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2224267, encodeId=2f23222426e0d, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：投的综述，选择了zhulin教授担任责任编辑，特别友好。我的综述写的特别认真。3个reviewer，一个说投稿方向部队拒稿，2个接收。提的建议有水平。非常有好的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d251311964, createdName=292082, createdTime=Thu Sep 05 16:04:14 CST 2024, time=2024-09-05, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2240114, encodeId=5213224011407, content=偏重的研究方向：中药 经验分享：投稿一个月了还在ea，一直没有分配编辑，周期真的有多长了 咨询了解一下，给到的结果也是说平均审稿周期事14周，确实是比较长的。 给的建议都是让再等等，到时再发邮件委婉的问一下。 有跟我一样的朋友可以蹲一下，互相交流交流, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822132, createdTime=Sat Nov 30 22:07:30 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2247723, encodeId=d689224e72311, content=期刊主要涵盖基础和临床药理学、药物化学、药毒理学等领域。 审稿周期在2至3个月内，期刊是OA期刊，版面费按文章类型收取，A类文章（原始研究、系统评价等）版面费较高，B类（迷你评论、观点等）、C类（数据报告、综合评论等）文章版面费依次降低。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722138, createdTime=Sun Jan 12 19:07:52 CST 2025, time=2025-01-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2172843, encodeId=b0c721e284362, content=各位大神们，请问提交WB原始数据是文章中出现的就行还是要提交三次重复的WB原始数据啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb4f8508995, createdName=ms5000001006994240, createdTime=Mon Dec 04 12:19:29 CST 2023, time=2023-12-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2207562, encodeId=ea40220e5622f, content=请问这个期刊上传原始数据是怎么操作的？是全部原始数据都要上传吗？是什么阶段需要上传呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=493d8448405, createdName=ms4000000094701757, createdTime=Thu May 30 23:35:00 CST 2024, time=2024-05-30, status=1, ipAttribution=广东省)]

2024-11-30 ms2000001788822132 来自上海

偏重的研究方向：中药
经验分享：投稿一个月了还在ea，一直没有分配编辑，周期真的有多长了
咨询了解一下，给到的结果也是说平均审稿周期事14周，确实是比较长的。
给的建议都是让再等等，到时再发邮件委婉的问一下。
有跟我一样的朋友可以蹲一下，互相交流交流

0 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2267516, encodeId=95d8226e516c2, content=相关期刊内容分享给大家，如有不对的地方欢迎纠正，一起交流学习。 最新影响因子：4.4（2023 JCR） 中科院分区：大类医学2区，小类药学2区 收录数据库：SCI-E、PubMed、Scopus、DOAJ等 OA模式：是，需支付版面费 投稿中一般1–4周就可以分配编辑，但是25存在延迟的情况，我看很多人稿件卡在“Editorial Assignment”超1个月 2-4周送审后需邀请2位以上审稿人。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms6000002977722155, createdTime=Sat May 31 22:26:33 CST 2025, time=2025-05-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2257407, encodeId=120c225e40762, content=想撤稿，应该如何操作呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6e762538727, createdName=小白白心态要稳, createdTime=Sun Mar 23 18:17:51 CST 2025, time=2025-03-23, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2256513, encodeId=928a22565139c, content=偏重的研究方向：中药 经验分享：投稿一个月了还在ea，一直没有分配编辑，焦虑 从评论区了解到该期刊的平均审稿周期是14周，个人觉得还是比较长的。 有跟我一样的朋友吗，大家一起来交流一下。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722150, createdTime=Mon Mar 17 23:15:17 CST 2025, time=2025-03-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1232891, encodeId=1d7912328916e, content=想问一下大家稿件停留在了Editorial Assignment阶段，已经三周了，编辑处显示了我选择编辑的名字，但是一直没有进展，我如果要给编辑发邮件的话，是通过Frontier的投稿官网页面给他发，还是找到编辑的邮箱私下询问呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230107/08d7227584d8419e9fc6eb0769470af8/651a32af4be94530b72739b0aea8ba0c.jpg, createdBy=ceb35641108, createdName=ms7000001549986178, createdTime=Sun Jul 17 00:40:05 CST 2022, time=2022-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2254108, encodeId=bda02254108c7, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;天然化合物;耐药 经验分享：请问投稿后遇到让重新提交的，是什么情况呢？是差什么材料，还是格式有问题吗？ Editorial Office Frontiers in Pharmacology Editorial Office requested resubmission of your manuscript. Please take action by 16 Mar 2025 on this request to either: resubmit the manuscript, or contact the editorial office., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce935708129, createdName=ms6000001686001327, createdTime=Sat Mar 01 16:25:55 CST 2025, time=2025-03-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2224267, encodeId=2f23222426e0d, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：投的综述，选择了zhulin教授担任责任编辑，特别友好。我的综述写的特别认真。3个reviewer，一个说投稿方向部队拒稿，2个接收。提的建议有水平。非常有好的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d251311964, createdName=292082, createdTime=Thu Sep 05 16:04:14 CST 2024, time=2024-09-05, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2240114, encodeId=5213224011407, content=偏重的研究方向：中药 经验分享：投稿一个月了还在ea，一直没有分配编辑，周期真的有多长了 咨询了解一下，给到的结果也是说平均审稿周期事14周，确实是比较长的。 给的建议都是让再等等，到时再发邮件委婉的问一下。 有跟我一样的朋友可以蹲一下，互相交流交流, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822132, createdTime=Sat Nov 30 22:07:30 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2247723, encodeId=d689224e72311, content=期刊主要涵盖基础和临床药理学、药物化学、药毒理学等领域。 审稿周期在2至3个月内，期刊是OA期刊，版面费按文章类型收取，A类文章（原始研究、系统评价等）版面费较高，B类（迷你评论、观点等）、C类（数据报告、综合评论等）文章版面费依次降低。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722138, createdTime=Sun Jan 12 19:07:52 CST 2025, time=2025-01-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2172843, encodeId=b0c721e284362, content=各位大神们，请问提交WB原始数据是文章中出现的就行还是要提交三次重复的WB原始数据啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb4f8508995, createdName=ms5000001006994240, createdTime=Mon Dec 04 12:19:29 CST 2023, time=2023-12-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2207562, encodeId=ea40220e5622f, content=请问这个期刊上传原始数据是怎么操作的？是全部原始数据都要上传吗？是什么阶段需要上传呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=493d8448405, createdName=ms4000000094701757, createdTime=Thu May 30 23:35:00 CST 2024, time=2024-05-30, status=1, ipAttribution=广东省)]

2025-01-12 ms5000002977722138 来自上海

期刊主要涵盖基础和临床药理学、药物化学、药毒理学等领域。
审稿周期在2至3个月内，期刊是OA期刊，版面费按文章类型收取，A类文章（原始研究、系统评价等）版面费较高，B类（迷你评论、观点等）、C类（数据报告、综合评论等）文章版面费依次降低。

34 0

[GetPortalCommentsPageByObjectIdResponse(id=2267516, encodeId=95d8226e516c2, content=相关期刊内容分享给大家，如有不对的地方欢迎纠正，一起交流学习。 最新影响因子：4.4（2023 JCR） 中科院分区：大类医学2区，小类药学2区 收录数据库：SCI-E、PubMed、Scopus、DOAJ等 OA模式：是，需支付版面费 投稿中一般1–4周就可以分配编辑，但是25存在延迟的情况，我看很多人稿件卡在“Editorial Assignment”超1个月 2-4周送审后需邀请2位以上审稿人。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms6000002977722155, createdTime=Sat May 31 22:26:33 CST 2025, time=2025-05-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2257407, encodeId=120c225e40762, content=想撤稿，应该如何操作呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6e762538727, createdName=小白白心态要稳, createdTime=Sun Mar 23 18:17:51 CST 2025, time=2025-03-23, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2256513, encodeId=928a22565139c, content=偏重的研究方向：中药 经验分享：投稿一个月了还在ea，一直没有分配编辑，焦虑 从评论区了解到该期刊的平均审稿周期是14周，个人觉得还是比较长的。 有跟我一样的朋友吗，大家一起来交流一下。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722150, createdTime=Mon Mar 17 23:15:17 CST 2025, time=2025-03-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1232891, encodeId=1d7912328916e, content=想问一下大家稿件停留在了Editorial Assignment阶段，已经三周了，编辑处显示了我选择编辑的名字，但是一直没有进展，我如果要给编辑发邮件的话，是通过Frontier的投稿官网页面给他发，还是找到编辑的邮箱私下询问呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230107/08d7227584d8419e9fc6eb0769470af8/651a32af4be94530b72739b0aea8ba0c.jpg, createdBy=ceb35641108, createdName=ms7000001549986178, createdTime=Sun Jul 17 00:40:05 CST 2022, time=2022-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2254108, encodeId=bda02254108c7, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;天然化合物;耐药 经验分享：请问投稿后遇到让重新提交的，是什么情况呢？是差什么材料，还是格式有问题吗？ Editorial Office Frontiers in Pharmacology Editorial Office requested resubmission of your manuscript. Please take action by 16 Mar 2025 on this request to either: resubmit the manuscript, or contact the editorial office., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce935708129, createdName=ms6000001686001327, createdTime=Sat Mar 01 16:25:55 CST 2025, time=2025-03-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2224267, encodeId=2f23222426e0d, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：投的综述，选择了zhulin教授担任责任编辑，特别友好。我的综述写的特别认真。3个reviewer，一个说投稿方向部队拒稿，2个接收。提的建议有水平。非常有好的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d251311964, createdName=292082, createdTime=Thu Sep 05 16:04:14 CST 2024, time=2024-09-05, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2240114, encodeId=5213224011407, content=偏重的研究方向：中药 经验分享：投稿一个月了还在ea，一直没有分配编辑，周期真的有多长了 咨询了解一下，给到的结果也是说平均审稿周期事14周，确实是比较长的。 给的建议都是让再等等，到时再发邮件委婉的问一下。 有跟我一样的朋友可以蹲一下，互相交流交流, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822132, createdTime=Sat Nov 30 22:07:30 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2247723, encodeId=d689224e72311, content=期刊主要涵盖基础和临床药理学、药物化学、药毒理学等领域。 审稿周期在2至3个月内，期刊是OA期刊，版面费按文章类型收取，A类文章（原始研究、系统评价等）版面费较高，B类（迷你评论、观点等）、C类（数据报告、综合评论等）文章版面费依次降低。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722138, createdTime=Sun Jan 12 19:07:52 CST 2025, time=2025-01-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2172843, encodeId=b0c721e284362, content=各位大神们，请问提交WB原始数据是文章中出现的就行还是要提交三次重复的WB原始数据啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb4f8508995, createdName=ms5000001006994240, createdTime=Mon Dec 04 12:19:29 CST 2023, time=2023-12-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2207562, encodeId=ea40220e5622f, content=请问这个期刊上传原始数据是怎么操作的？是全部原始数据都要上传吗？是什么阶段需要上传呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=493d8448405, createdName=ms4000000094701757, createdTime=Thu May 30 23:35:00 CST 2024, time=2024-05-30, status=1, ipAttribution=广东省)]

2023-12-04 ms5000001006994240 来自山东省

各位大神们，请问提交WB原始数据是文章中出现的就行还是要提交三次重复的WB原始数据啊？

150 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2267516, encodeId=95d8226e516c2, content=相关期刊内容分享给大家，如有不对的地方欢迎纠正，一起交流学习。 最新影响因子：4.4（2023 JCR） 中科院分区：大类医学2区，小类药学2区 收录数据库：SCI-E、PubMed、Scopus、DOAJ等 OA模式：是，需支付版面费 投稿中一般1–4周就可以分配编辑，但是25存在延迟的情况，我看很多人稿件卡在“Editorial Assignment”超1个月 2-4周送审后需邀请2位以上审稿人。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms6000002977722155, createdTime=Sat May 31 22:26:33 CST 2025, time=2025-05-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2257407, encodeId=120c225e40762, content=想撤稿，应该如何操作呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6e762538727, createdName=小白白心态要稳, createdTime=Sun Mar 23 18:17:51 CST 2025, time=2025-03-23, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2256513, encodeId=928a22565139c, content=偏重的研究方向：中药 经验分享：投稿一个月了还在ea，一直没有分配编辑，焦虑 从评论区了解到该期刊的平均审稿周期是14周，个人觉得还是比较长的。 有跟我一样的朋友吗，大家一起来交流一下。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722150, createdTime=Mon Mar 17 23:15:17 CST 2025, time=2025-03-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1232891, encodeId=1d7912328916e, content=想问一下大家稿件停留在了Editorial Assignment阶段，已经三周了，编辑处显示了我选择编辑的名字，但是一直没有进展，我如果要给编辑发邮件的话，是通过Frontier的投稿官网页面给他发，还是找到编辑的邮箱私下询问呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230107/08d7227584d8419e9fc6eb0769470af8/651a32af4be94530b72739b0aea8ba0c.jpg, createdBy=ceb35641108, createdName=ms7000001549986178, createdTime=Sun Jul 17 00:40:05 CST 2022, time=2022-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2254108, encodeId=bda02254108c7, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;天然化合物;耐药 经验分享：请问投稿后遇到让重新提交的，是什么情况呢？是差什么材料，还是格式有问题吗？ Editorial Office Frontiers in Pharmacology Editorial Office requested resubmission of your manuscript. Please take action by 16 Mar 2025 on this request to either: resubmit the manuscript, or contact the editorial office., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce935708129, createdName=ms6000001686001327, createdTime=Sat Mar 01 16:25:55 CST 2025, time=2025-03-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2224267, encodeId=2f23222426e0d, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：投的综述，选择了zhulin教授担任责任编辑，特别友好。我的综述写的特别认真。3个reviewer，一个说投稿方向部队拒稿，2个接收。提的建议有水平。非常有好的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d251311964, createdName=292082, createdTime=Thu Sep 05 16:04:14 CST 2024, time=2024-09-05, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2240114, encodeId=5213224011407, content=偏重的研究方向：中药 经验分享：投稿一个月了还在ea，一直没有分配编辑，周期真的有多长了 咨询了解一下，给到的结果也是说平均审稿周期事14周，确实是比较长的。 给的建议都是让再等等，到时再发邮件委婉的问一下。 有跟我一样的朋友可以蹲一下，互相交流交流, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822132, createdTime=Sat Nov 30 22:07:30 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2247723, encodeId=d689224e72311, content=期刊主要涵盖基础和临床药理学、药物化学、药毒理学等领域。 审稿周期在2至3个月内，期刊是OA期刊，版面费按文章类型收取，A类文章（原始研究、系统评价等）版面费较高，B类（迷你评论、观点等）、C类（数据报告、综合评论等）文章版面费依次降低。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722138, createdTime=Sun Jan 12 19:07:52 CST 2025, time=2025-01-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2172843, encodeId=b0c721e284362, content=各位大神们，请问提交WB原始数据是文章中出现的就行还是要提交三次重复的WB原始数据啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb4f8508995, createdName=ms5000001006994240, createdTime=Mon Dec 04 12:19:29 CST 2023, time=2023-12-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2207562, encodeId=ea40220e5622f, content=请问这个期刊上传原始数据是怎么操作的？是全部原始数据都要上传吗？是什么阶段需要上传呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=493d8448405, createdName=ms4000000094701757, createdTime=Thu May 30 23:35:00 CST 2024, time=2024-05-30, status=1, ipAttribution=广东省)]

2024-05-30 ms4000000094701757 来自广东省

请问这个期刊上传原始数据是怎么操作的？是全部原始数据都要上传吗？是什么阶段需要上传呀？

119 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务